Compare HSBC Holdings plc (HSBC) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HSBC Holdings plc vs Koninklijke Philips NV — how do they compare? HSBC Holdings plc trades at $101.41 (market cap $335.21B), while Koninklijke Philips NV trades at $26.61 (market cap $26.19B). The key difference: HSBC Holdings plc is far larger — about 12.8× Koninklijke Philips NV's market cap, and HSBC Holdings plc is trading nearer its 52-week high, Koninklijke Philips NV nearer its low. Which is the better fit depends on your goals.
| HSBC | PHG | |
|---|---|---|
Market Cap | $335.21B | $26.19B |
Sector | Technology | Health |
52-Week High | $100.61 | $32.91 |
52-Week Low | $61.30 | $24.54 |
Dividend Yield | 3.79% | 3.79% |
Enterprise Value | — | $32.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HSBC trades at $99.01, down 1.59% today but near its 52-week high of $99.47. The stock shows strong technical momentum with bullish moving averages, though oscillators suggest potential overbought conditions. Fundamentally, the bank maintains robust profitability with 30.81% net income margin and 10.89% ROE, supported by recent earnings beats and a $0.50 dividend declaration. Recent news highlights strategic moves including AI partnerships and business portfolio optimization.
HSBC presents a mixed outlook with solid fundamentals and strategic initiatives balanced against valuation concerns and regional risks. The bank's focus on AI integration and market exits could drive efficiency, but regulatory challenges and economic uncertainty pose headwinds. Analyst consensus leans cautious with 38% buy ratings, suggesting selective opportunity for long-term investors despite near-term overbought signals.
PHG trades at $26.80, down 0.56% with bearish technical signals. The company shows improved fundamentals with net income turning positive to $895M in 2025 after previous losses, though revenue declined slightly to $17.83B. Analyst consensus is mixed with 40.9% buy ratings but technical indicators show selling pressure. Recent developments include FDA clearances for AI-powered medical devices and strategic healthcare partnerships.
PHG presents a turnaround story with profitability recovery but faces execution risks amid competitive pressures. The stock offers value at reasonable valuations (P/E 23.67, P/S 1.29) but requires monitoring of revenue stabilization and AI product adoption. Near-term catalyst includes Q2 2026 earnings with expected EPS of $0.40.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
